[{"address1": "7495 New Horizon Way", "city": "Frederick", "state": "MD", "zip": "21703", "country": "United States", "phone": "301 348 8698", "website": "https://www.cartesiantherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA CAR-T directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, an autologous anti-BCMA mRNA CAR-T to treat autoimmune diseases, such as relapsed/refractory multiple myeloma. The company is headquartered in Frederick, Maryland.", "fullTimeEmployees": 66, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carsten  Brunn Ph.D.", "age": 53, "title": "President, CEO & Director", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 1104431, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Blaine T. Davis", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 737112, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chris  Jewell Ph.D.", "age": 42, "title": "Chief Scientific Officer", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 649666, "exercisedValue": 0, "unexercisedValue": 882107}, {"maxAge": 1, "name": "Dr. Metin  Kurtoglu M.D., Ph.D.", "age": 45, "title": "Consultant", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 669907, "exercisedValue": 0, "unexercisedValue": 1619007}, {"maxAge": 1, "name": "Dr. Emily  English Ph.D.", "age": 44, "title": "Chief Operating Officer", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew  Bartholomae J.D.", "title": "General Counsel & Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Milos  Miljkovic M.D., Ph.D.", "age": 40, "title": "Chief Medical Officer", "yearBorn": 1984, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.39, "open": 10.285, "dayLow": 10.285, "dayHigh": 11.2, "regularMarketPreviousClose": 10.39, "regularMarketOpen": 10.285, "regularMarketDayLow": 10.285, "regularMarketDayHigh": 11.2, "payoutRatio": 0.0, "trailingPE": 2.0825517, "forwardPE": -3.1805158, "volume": 33113, "regularMarketVolume": 33113, "averageVolume": 90036, "averageVolume10days": 79850, "averageDailyVolume10Day": 79850, "bid": 10.84, "ask": 11.42, "bidSize": 1, "askSize": 1, "marketCap": 288092736, "fiftyTwoWeekLow": 8.46, "fiftyTwoWeekHigh": 26.5, "priceToSalesTrailing12Months": 8.43042, "fiftyDayAverage": 10.4984, "twoHundredDayAverage": 16.275375, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 103297080, "profitMargins": -1.12106, "floatShares": 9342507, "sharesOutstanding": 25954300, "sharesShort": 2627712, "sharesShortPriorMonth": 2506042, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.1012, "heldPercentInsiders": 0.59959, "heldPercentInstitutions": 0.25631002, "shortRatio": 39.45, "shortPercentOfFloat": 0.2551, "impliedSharesOutstanding": 26566300, "bookValue": -0.84, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -38310000, "trailingEps": 5.33, "forwardEps": -3.49, "lastSplitFactor": "1:30", "lastSplitDate": 1712275200, "enterpriseToRevenue": 3.023, "enterpriseToEbitda": -2.446, "52WeekChange": -0.3411541, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 11.1, "targetHighPrice": 42.0, "targetLowPrice": 16.0, "targetMeanPrice": 36.16667, "targetMedianPrice": 40.0, "recommendationKey": "none", "numberOfAnalystOpinions": 6, "totalCash": 180434000, "totalCashPerShare": 6.952, "ebitda": -42235000, "totalDebt": 14066000, "quickRatio": 12.148, "currentRatio": 12.343, "totalRevenue": 34173000, "revenuePerShare": 1.526, "returnOnAssets": -0.07551, "grossProfits": -15868000, "freeCashflow": -47633376, "operatingCashflow": -30865000, "revenueGrowth": -0.812, "grossMargins": -0.46433997, "ebitdaMargins": -1.2359201, "operatingMargins": -19.89909, "financialCurrency": "USD", "symbol": "RNAC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 6.8334937, "regularMarketPrice": 11.1, "corporateActions": [], "regularMarketTime": 1751395808, "exchange": "NGM", "messageBoardId": "finmb_371375105", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Cartesian Therapeutics, Inc.", "marketState": "REGULAR", "regularMarketChange": 0.71000004, "regularMarketDayRange": "10.285 - 11.2", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 90036, "fiftyTwoWeekLowChange": 2.6400003, "fiftyTwoWeekLowChangePercent": 0.31205678, "fiftyTwoWeekRange": "8.46 - 26.5", "fiftyTwoWeekHighChange": -15.4, "fiftyTwoWeekHighChangePercent": -0.58113205, "fiftyTwoWeekChangePercent": -34.11541, "earningsTimestamp": 1746702002, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754915400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 5.33, "epsForward": -3.49, "fiftyDayAverageChange": 0.60160065, "fiftyDayAverageChangePercent": 0.057304032, "longName": "Cartesian Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1466602200000, "twoHundredDayAverageChange": -5.175375, "twoHundredDayAverageChangePercent": -0.31798807, "priceToBook": -13.214287, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Cartesian Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]